Search Results - "Vanveldhuizen, Peter J"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients by Womble, Paul R, VanVeldhuizen, Peter J, Nisbet, Alan A, Reed, Greg A, Thrasher, J Brantley, Holzbeierlein, Jeffrey M

    Published in The Journal of urology (01-09-2011)
    “…Patients with high risk prostate cancer (prostate specific antigen greater than 20 ng/ml, Gleason score greater than 7, or clinical stage T2b or greater) have…”
    Get more information
    Journal Article
  2. 2

    Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2 by Dhar, Gopal, Banerjee, Snigdha, Dhar, Kakali, Tawfik, Ossama, Mayo, Matthew S, Vanveldhuizen, Peter J, Banerjee, Sushanta K

    Published in Cancer research (Chicago, Ill.) (15-06-2008)
    “…CCN5/WISP-2 is overexpressed in noninvasive breast cancer cells and tissue samples, whereas its expression is minimal or undetected in invasive conditions…”
    Get full text
    Journal Article
  3. 3

    Leiomyosarcoma of the inferior vena cava: a case report and review of the literature by Reddy, Venkataprasanth P, Vanveldhuizen, Peter J, Muehlebach, Gregory F, Dusing, Reginald W, Birkbeck, James P, Williamson, Stephen K, Krishnan, Leela, Meyers, David G

    Published in Cases journal (23-02-2010)
    “…A 68-year-old white female presented with two years of progressively worsening dyspnea. Echocardiography revealed a large right atrial mass and partial…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue by Vanveldhuizen, Peter J, Zulfiqar, Muhammad, Banerjee, Snigdha, Cherian, Rachel, Saxena, Neela K, Rabe, Amy, Thrasher, J Brantley, Banerjee, Sushanta K

    Published in Oncology reports (01-09-2003)
    “…Neuropilin-1 (NRP-1), a co-receptor for VEGF165, is overexpressed in various prostate cancer cell lines and in advanced prostate tumors. However, distribution…”
    Get more information
    Journal Article
  6. 6

    Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study by Urba, Susan G, Chansky, Kari, VanVeldhuizen, Peter J, Pluenneke, Robert E, Benedetti, Jacqueline K, Macdonald, John S, Abbruzzese, James L

    Published in Investigational new drugs (01-01-2004)
    “…Experimental data, both in vivo and in vitro, suggest that the combination of gemcitabine and cisplatin acts synergistically. Within the Southwest Oncology…”
    Get full text
    Journal Article
  7. 7

    Abstract 5654: Docetaxel followed by temsirolimus suppresses mTOR pathway and can overcome PI3K / AKT over activation mechanism of resistance in lung cancer cell line by Huang, Chao H., VanVeldhuizen, Peter J., Williamson, Stephen K., Gadashova, Ayten, Farassati, Faris

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Background: Mammalian target of rapamycin (mTOR) is a downstream regulatory protein of PI3K/AKT signal transduction pathway. The activation of cell…”
    Get full text
    Journal Article
  8. 8

    Abstract 5160: Tumor cells potentiate mesenchymal stem cells-pericytes transition and requirement through PDGF-BB-NRP-1 axis by Dhar, Kakali, Dhar, Gopal, Majumder, Monami, Haque, Inamul, Banerjee, Sushanta K., Mehta, Smita, Vanveldhuizen, Peter J., Banerjee, Snigdha

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract New blood vessel formation or angiogenic switch is an essential event in the development of solid tumors and their metastatic growth. Tumor blood…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Biclonal post-transplant B-cell lymphoma: report of a case with two distinct cell populations, XX,t(14;18) and XY,t(11;14) by Dennis, Katie L, Wallentine, Steven L, Vanveldhuizen, Peter J, Persons, Diane L, Mathur, Sharad C

    Published in Cancer genetics and cytogenetics (01-03-2007)
    “…Abstract Lymphoproliferative disorders are more likely to occur in transplant patients compared to the general population. Typically in these patients,…”
    Get full text
    Journal Article